Literature DB >> 19965829

Ahmed glaucoma valves in refractory glaucoma: a 7-year audit.

Peter K Wishart1, Anshoo Choudhary, David Wong.   

Abstract

PURPOSE: To present the long-term results of Ahmed glaucoma valve (AGV) implantation.
METHODS: Consecutive case series of 94 eyes with AGV implantation over 7 years. Temporary tube ligation with C3F8 gas fill was used in high-risk eyes (group G&L) and compared with standard implantation in both phakic (group A) and pseudophakic/aphakic eyes (group B). Success was intraocular pressure (IOP) of 6 mm Hg or greater and 21 mm Hg or less and/or IOP reduction of 20% or greater.
RESULTS: Average follow-up was 28.9+/-20.3 months. The mean preoperative IOP changed from 30.8+/-8.2 to 19.7+/-7.6 mm Hg and mean preoperative medications changed from 3.3+/-1.2 to 1.2+/-1.1 at the final visit. Cumulative probability of survival at 1 and 4 years was 89.1% and 72.9%. There was no statistically significant difference in success between the three groups, but complications due to postoperative hypotony (six eyes) only occurred in group B. Other complications were corneal decompensation (three eyes), tube erosion (six eyes) and aqueous misdirection (four eyes).
CONCLUSIONS: AGV implantation offered good long-term IOP control with a success rate of 78.7%. The authors recommend C3F8 gas fill and temporary tube ligation in eyes at high risk of postoperative hypotony and the use of donor sclera or human pericardial patch to prevent tube erosion.

Entities:  

Mesh:

Year:  2009        PMID: 19965829     DOI: 10.1136/bjo.2009.165357

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Complications due to bovine pericardium used to cover acrylic implants after enucleation and tubes of aqueous devices.

Authors:  F R De Vries; I C Notting; M Marinkovic; N E Schalij-Delfos; G P M Luyten
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

2.  [Ahmed glaucoma valve via pars plana access. Long-term results of implantation for therapy refractive glaucoma].

Authors:  B Mazinani; H Schwarzer; A Willkomm; A Weinberger; N Plange; P Walter; G Rössler
Journal:  Ophthalmologe       Date:  2013-06       Impact factor: 1.059

3.  Membrane-tube-type glaucoma shunt device for refractory glaucoma surgery.

Authors:  Jong Chul Han; Young Hoon Hwang; Byung Heon Ahn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-20       Impact factor: 3.117

4.  Outcomes of Ahmed valve surgery for refractory glaucoma in Dhahran, Saudi Arabia.

Authors:  Tariq Alasbali; Abdullah Ali Alghamdi; Rajiv Khandekar
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  The role of primary needle revision after Ahmed glaucoma valve (AGV) implantation.

Authors:  Maryam Yadgari; Kiana Hassanpour; Fatemeh Vafaei
Journal:  Int Ophthalmol       Date:  2020-08-27       Impact factor: 2.031

6.  Long-term results of Ahmed glaucoma valve implantation in Egyptian population.

Authors:  Eman Elhefney; Tharwat Mokbel; Waleed Abou Samra; Hanem Kishk; Tarek Mohsen; Amr El-Kannishy
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

7.  Combined Scleral Flap with Donor Scleral Patch Graft for Anterior Tube Placement in Glaucoma Drainage Device Surgery.

Authors:  Jea H Yu; Chuck Nguyen; Esmeralda Gallemore; Ron P Gallemore
Journal:  Case Rep Ophthalmol Med       Date:  2016-09-25

8.  Short term outcome of Ahmed glaucoma valve implantation in management of refractory glaucoma in a tertiary hospital in Oman.

Authors:  Manali R Shah; Rajiv B Khandekar; Rajiv Zutshi; Rahima Mahrooqi
Journal:  Oman J Ophthalmol       Date:  2013-01

9.  Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery.

Authors:  Meenakshi Chaku; Peter A Netland; Kyoko Ishida; Douglas J Rhee
Journal:  Clin Ophthalmol       Date:  2016-03-30

10.  New Technique of Exposed Glaucoma Drainage Tube Repair: Report of a Case.

Authors:  Tamara L Berezina; Robert D Fechtner; Amir Cohen; Eliott E Kim; David S Chu
Journal:  J Curr Glaucoma Pract       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.